Availability online of the sanofi-aventis half-year financial statement for 2007 Sanofi-aventis announces that its half-year financial statement for 2007 is currently available. About sanofi-aventis Sanofi-aventis is among the world’s leading pharmaceutical businesses, ranking number 1 in European countries. Backed by way of a world-course R&D organisation, sanofi-aventis is normally developing leading positions in seven main therapeutic areas: cardiovascular, thrombosis, oncology, metabolic illnesses, central nervous program, internal vaccines and medicine. Sanofi-aventis is shown in Paris and in NY .Of program, given accelerated climate switch, extreme climate is fast becoming typical. For all these good reasons, millions of American individuals are embracing organic foods and additional organic items, including body and clothing maintenance systems – part of a standard movement toward healthful living, preserving the surroundings, and reversing global warming.. CU-Boulder develops inhalable vaccine for measles prevention Dry powder vaccine set for clinical trials this season in IndiaA team of researchers led by the University of Colorado at Boulder believe a dry powder, inhalable vaccine developed for measles prevention and slated for individual clinical trials later on this year in India will lead to additional inhalable, inexpensive vaccines for illnesses ranging from tuberculosis to cervical cancers.

Other articles from category "oncology":

Random articles